Deniz Taşdemir
Deniz Taşdemir has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Murat Haksever
Department of Perinatology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey
8 shared publications - Refaettin Şahin
Department of Obstetrics and Gynecology, Istinye University Faculty of Medicine, Liv Hospital, Istanbul, Turkey
4 shared publications - Bekir Kahveci
Department of Obstetrics and Gynecology, Çukurova University, Adana, Turkey
3 shared publications - Selim Kandemir
Department of Gynecologic Oncology, Sanliurfa Training and Research Hospital, Sanliurfa 63250, Turkey
3 shared publications - Alp Koray Kinter
Department of Obstetrics and Gynecology, Division of Gynecologic Oncologic Surgery, Istinye University, Istanbul, Turkey
2 shared publications - Ismet Hortu
Department of Obstetrics and Gynecology, Ege University School of Medicine
2 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (6) , 1565-1573
Multimarker versus biochemical first-trimester risk assessment for fetal chromosomal anomalies: a retrospective cohort study
Aims: To compare the diagnostic performance of biochemical risk assessment alone with that of a multimarker first-trimester risk assessment combining biochemical and sonographic parameters for screening of fetal chromosomal anomalies. Methods: This retrospective observational study included singleton pregnancies evaluated at a tertiary perinatology clinic between January 2022 and January 2026. Pregnancies undergoing first-trimester screening at 11+0 to 13+6 weeks of gestation were included. Biochemical risk was calculated using maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A, whereas multimarker risk was derived from maternal characteristics, biochemical markers, and sonographic findings, including nuchal translucency and selected additional markers when available. The primary outcome was confirmed fetal chromosomal anomaly. Diagnostic indices and receiver operating characteristic (ROC) analyses were performed. Results: A total of 1,248 singleton pregnancies were analyzed, including 42 fetuses (3.4%) with chromosomal anomalies. Compared with the biochemical model, the multimarker model showed higher sensitivity (81.0% vs 69.0%), specificity (95.7% vs 92.6%), positive predictive value (39.5% vs 24.6%), and overall accuracy (95.2% vs 91.8%). The false-positive rate was lower with the multimarker approach (4.3% vs 7.4%). ROC analysis demonstrated superior discriminative performance for the multimarker model (AUC: 0.903 vs 0.812, p<0.001). Conclusion: Multimarker first-trimester risk assessment provided better overall diagnostic performance than biochemical risk assessment alone, particularly in terms of specificity, accuracy, and reduction of false-positive results. These estimates should be interpreted in light of the retrospective design, partial verification bias, and the limited number of affected pregnancies.
- 25 October 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (6) , 1565-1573
Open AccessMultimarker versus biochemical first-trimester risk assessment for fetal chromosomal anomalies: a retrospective cohort study
Aims: To compare the diagnostic performance of biochemical risk assessment alone with that of a multimarker first-trimester risk assessment combining biochemical and sonographic parameters for screening of fetal chromosomal anomalies. Methods: This retrospective observational study included singleton pregnancies evaluated at a tertiary perinatology clinic between January 2022 and January 2026. Pregnancies undergoing first-trimester screening at 11+0 to 13+6 weeks of gestation were included. Biochemical risk was calculated using maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A, whereas multimarker risk was derived from maternal characteristics, biochemical markers, and sonographic findings, including nuchal translucency and selected additional markers when available. The primary outcome was confirmed fetal chromosomal anomaly. Diagnostic indices and receiver operating characteristic (ROC) analyses were performed. Results: A total of 1,248 singleton pregnancies were analyzed, including 42 fetuses (3.4%) with chromosomal anomalies. Compared with the biochemical model, the multimarker model showed higher sensitivity (81.0% vs 69.0%), specificity (95.7% vs 92.6%), positive predictive value (39.5% vs 24.6%), and overall accuracy (95.2% vs 91.8%). The false-positive rate was lower with the multimarker approach (4.3% vs 7.4%). ROC analysis demonstrated superior discriminative performance for the multimarker model (AUC: 0.903 vs 0.812, p<0.001). Conclusion: Multimarker first-trimester risk assessment provided better overall diagnostic performance than biochemical risk assessment alone, particularly in terms of specificity, accuracy, and reduction of false-positive results. These estimates should be interpreted in light of the retrospective design, partial verification bias, and the limited number of affected pregnancies.
- Open Access
- 17 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2370
Incremental Prognostic Value of Fetal Doppler Beyond Biometry for Adverse Perinatal Outcomes in Suspected Fetal Growth Restriction: A Retrospective Cohort Study
Objective: To explore the incremental prognostic information of fetal Doppler measurements beyond maternal and fetal biometric characteristics for adverse perinatal outcomes in pregnancies with suspected fetal smallness. Methods: This retrospective cohort study included 606 singleton pregnancies assessed for suspected or diagnosed fetal growth restriction. The principal analysis was restricted to 429 pregnancies with estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile at the index examination. A composite adverse perinatal outcome comprised five-minute Apgar score < 7, umbilical arterial pH < 7.10, neonatal intensive care unit (NICU) admission, respiratory support, neonatal death, or stillbirth. Baseline clinical–biometric, Doppler-integrated, and delivery-week sensitivity logistic models were assessed using stratified 10-fold out-of-fold predictions. Additional robustness analyses evaluated component frequencies, a hard-outcome sensitivity composite less directly influenced by clinical management, paired uncertainty in out-of-fold performance differences, and model performance across alternative cohort definitions. Results: Among 429 pregnancies in the principal cohort, 111 (25.9%) met the composite adverse perinatal outcome, and 206 (48.0%) had abnormal Doppler findings. Event rates were 85/206 (41.3%) among pregnancies with abnormal Doppler and 26/223 (11.7%) among those with normal Doppler. The baseline and Doppler-integrated out-of-fold areas under the receiver operating characteristic curve (AUCs) were 0.642 and 0.690, respectively; corresponding Brier scores were 0.183 and 0.174. Elevated umbilical artery pulsatility index with forward flow and absent or reversed end-diastolic flow (AEDF/REDF) were independently associated with the composite outcome, with adjusted odds ratios of 2.61 (95% confidence interval [CI], 1.58–4.32) and 6.60 (95% CI, 2.40–18.18), respectively, compared with normal umbilical artery flow. The adjusted estimate for the AEDF/REDF subgroup was imprecise because this subgroup included only 19 pregnancies. The paired out-of-fold AUC increment for the Doppler-integrated model was 0.049 (95% CI, 0.005–0.094); the corresponding Brier-score improvement was 0.009 (95% CI, −0.0004 to 0.0179). Sensitivity analyses supported a modest incremental contribution but did not establish the superiority of the integrated model over alternatives based on the cerebroplacental ratio (CPR) or umbilical artery (UA) Doppler. Conclusions: In pregnancies with suspected fetal smallness defined by EFW or AC below the 10th percentile, fetal Doppler assessment provided modest incremental prognostic information beyond maternal and fetal biometric characteristics. Umbilical artery abnormalities were associated with the composite adverse perinatal outcome, although this association should be interpreted in the context of delivery timing and clinical management. External validation and assessment of clinical utility are required before clinical implementation of the model.
- 17 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2370
Open AccessIncremental Prognostic Value of Fetal Doppler Beyond Biometry for Adverse Perinatal Outcomes in Suspected Fetal Growth Restriction: A Retrospective Cohort Study
Objective: To explore the incremental prognostic information of fetal Doppler measurements beyond maternal and fetal biometric characteristics for adverse perinatal outcomes in pregnancies with suspected fetal smallness. Methods: This retrospective cohort study included 606 singleton pregnancies assessed for suspected or diagnosed fetal growth restriction. The principal analysis was restricted to 429 pregnancies with estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile at the index examination. A composite adverse perinatal outcome comprised five-minute Apgar score < 7, umbilical arterial pH < 7.10, neonatal intensive care unit (NICU) admission, respiratory support, neonatal death, or stillbirth. Baseline clinical–biometric, Doppler-integrated, and delivery-week sensitivity logistic models were assessed using stratified 10-fold out-of-fold predictions. Additional robustness analyses evaluated component frequencies, a hard-outcome sensitivity composite less directly influenced by clinical management, paired uncertainty in out-of-fold performance differences, and model performance across alternative cohort definitions. Results: Among 429 pregnancies in the principal cohort, 111 (25.9%) met the composite adverse perinatal outcome, and 206 (48.0%) had abnormal Doppler findings. Event rates were 85/206 (41.3%) among pregnancies with abnormal Doppler and 26/223 (11.7%) among those with normal Doppler. The baseline and Doppler-integrated out-of-fold areas under the receiver operating characteristic curve (AUCs) were 0.642 and 0.690, respectively; corresponding Brier scores were 0.183 and 0.174. Elevated umbilical artery pulsatility index with forward flow and absent or reversed end-diastolic flow (AEDF/REDF) were independently associated with the composite outcome, with adjusted odds ratios of 2.61 (95% confidence interval [CI], 1.58–4.32) and 6.60 (95% CI, 2.40–18.18), respectively, compared with normal umbilical artery flow. The adjusted estimate for the AEDF/REDF subgroup was imprecise because this subgroup included only 19 pregnancies. The paired out-of-fold AUC increment for the Doppler-integrated model was 0.049 (95% CI, 0.005–0.094); the corresponding Brier-score improvement was 0.009 (95% CI, −0.0004 to 0.0179). Sensitivity analyses supported a modest incremental contribution but did not establish the superiority of the integrated model over alternatives based on the cerebroplacental ratio (CPR) or umbilical artery (UA) Doppler. Conclusions: In pregnancies with suspected fetal smallness defined by EFW or AC below the 10th percentile, fetal Doppler assessment provided modest incremental prognostic information beyond maternal and fetal biometric characteristics. Umbilical artery abnormalities were associated with the composite adverse perinatal outcome, although this association should be interpreted in the context of delivery timing and clinical management. External validation and assessment of clinical utility are required before clinical implementation of the model.
- Open Access
- 15 August 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (4) , 669-675
Fibrinogen-to-shock index ratio as a novel predictor of severity in placental abruption: a retrospective cohort study
Aims: To evaluate the predictive value of the fibrinogen-to-shock index (FSI) ratio for identifying severe placental abruption and to compare its performance with fibrinogen and shock index alone. Methods: This retrospective cohort study included 136 pregnant women diagnosed with placental abruption at a tertiary perinatology center. Patients were classified as having mild/moderate abruption (n=86) or severe abruption (n=50). Demographic, clinical, laboratory, maternal, and neonatal outcome data were analyzed. The shock index was calculated as heart rate divided by systolic blood pressure, and the FSI ratio was derived by dividing fibrinogen by shock index. Univariate and multivariate logistic regression analyses were performed to determine predictors of severe abruption. Receiver operating characteristic (ROC) analysis, Youden index-based cut-off analysis, and decision curve analysis were used to assess discriminative performance and clinical utility. Results: Patients with severe placental abruption had significantly lower hemoglobin and fibrinogen levels and a significantly higher shock index than those with mild/moderate abruption (all p
- 15 August 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (4) , 669-675
Open AccessFibrinogen-to-shock index ratio as a novel predictor of severity in placental abruption: a retrospective cohort study
Aims: To evaluate the predictive value of the fibrinogen-to-shock index (FSI) ratio for identifying severe placental abruption and to compare its performance with fibrinogen and shock index alone. Methods: This retrospective cohort study included 136 pregnant women diagnosed with placental abruption at a tertiary perinatology center. Patients were classified as having mild/moderate abruption (n=86) or severe abruption (n=50). Demographic, clinical, laboratory, maternal, and neonatal outcome data were analyzed. The shock index was calculated as heart rate divided by systolic blood pressure, and the FSI ratio was derived by dividing fibrinogen by shock index. Univariate and multivariate logistic regression analyses were performed to determine predictors of severe abruption. Receiver operating characteristic (ROC) analysis, Youden index-based cut-off analysis, and decision curve analysis were used to assess discriminative performance and clinical utility. Results: Patients with severe placental abruption had significantly lower hemoglobin and fibrinogen levels and a significantly higher shock index than those with mild/moderate abruption (all p
- Open Access
- 12 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6234
First-Trimester Hemoglobin-to-RDW Ratio in Pregnancies Subsequently Complicated by Preeclampsia: Association, Discrimination, and Clinical Interpretability in a Retrospective Cohort
Background/Objectives: Preeclampsia is a heterogeneous hypertensive disorder of pregnancy, and accessible hematologic indices may reflect maternal physiologic differences before the clinical syndrome becomes evident. This study evaluated whether the first-trimester hemoglobin-to-red cell distribution width (Hb/RDW) ratio was associated with later documented preeclampsia and assessed its discrimination, relation to disease severity, and association with maternal–neonatal outcomes in a tertiary-care cohort. Methods: This retrospective cohort study included 224 singleton pregnancies managed at a tertiary referral center between January 2024 and December 2025. Data extraction, anonymization, and analysis were performed after ethics approval (Approval No. 72; 2 March 2026). Participants were categorized as preeclampsia-negative (n = 131) or preeclampsia-positive (n = 93). Preeclampsia and severe features were defined according to American College of Obstetricians and Gynecologists criteria. The Hb/RDW ratio was calculated from routine first-trimester complete blood count parameters obtained before clinical diagnosis or final outcome classification. ROC analysis, multivariable logistic regression, multicollinearity assessment, events-per-variable evaluation, calibration testing, and exploratory incremental discrimination analyses were performed. Results: The first-trimester Hb/RDW ratio was higher in pregnancies later complicated by preeclampsia. Single-marker ROC analysis showed moderate discrimination (AUC = 0.687; bootstrap 95% CI: 0.618–0.755). At the 0.63 cut-off, sensitivity was 89.2%, specificity 47.3%, positive predictive value 54.6%, and negative predictive value 86.1%. In the primary multivariable model, Hb/RDW remained associated with later preeclampsia (adjusted OR per 0.1-unit increase = 1.45; 95% CI: 1.22–1.72; p < 0.001). However, Hb/RDW was not independently associated with severe preeclampsia among affected patients, fetal growth restriction, or composite maternal morbidity. VIF values ranged from 1.00 to 1.07. Secondary models for fetal growth restriction and composite maternal morbidity had borderline events-per-variable values and were interpreted as exploratory. Conclusions: First-trimester Hb/RDW was associated with later documented preeclampsia in this retrospective tertiary-care cohort, but its single-marker performance was modest and specificity was limited. The ratio should be interpreted as an inexpensive research marker of hematologic phenotype rather than a stand-alone screening, diagnostic, or management tool. Prospective multicenter validation with standardized first-trimester sampling and adjustment for hematinic and nutritional variables is required before clinical implementation.
- 12 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6234
Open AccessFirst-Trimester Hemoglobin-to-RDW Ratio in Pregnancies Subsequently Complicated by Preeclampsia: Association, Discrimination, and Clinical Interpretability in a Retrospective Cohort
Background/Objectives: Preeclampsia is a heterogeneous hypertensive disorder of pregnancy, and accessible hematologic indices may reflect maternal physiologic differences before the clinical syndrome becomes evident. This study evaluated whether the first-trimester hemoglobin-to-red cell distribution width (Hb/RDW) ratio was associated with later documented preeclampsia and assessed its discrimination, relation to disease severity, and association with maternal–neonatal outcomes in a tertiary-care cohort. Methods: This retrospective cohort study included 224 singleton pregnancies managed at a tertiary referral center between January 2024 and December 2025. Data extraction, anonymization, and analysis were performed after ethics approval (Approval No. 72; 2 March 2026). Participants were categorized as preeclampsia-negative (n = 131) or preeclampsia-positive (n = 93). Preeclampsia and severe features were defined according to American College of Obstetricians and Gynecologists criteria. The Hb/RDW ratio was calculated from routine first-trimester complete blood count parameters obtained before clinical diagnosis or final outcome classification. ROC analysis, multivariable logistic regression, multicollinearity assessment, events-per-variable evaluation, calibration testing, and exploratory incremental discrimination analyses were performed. Results: The first-trimester Hb/RDW ratio was higher in pregnancies later complicated by preeclampsia. Single-marker ROC analysis showed moderate discrimination (AUC = 0.687; bootstrap 95% CI: 0.618–0.755). At the 0.63 cut-off, sensitivity was 89.2%, specificity 47.3%, positive predictive value 54.6%, and negative predictive value 86.1%. In the primary multivariable model, Hb/RDW remained associated with later preeclampsia (adjusted OR per 0.1-unit increase = 1.45; 95% CI: 1.22–1.72; p < 0.001). However, Hb/RDW was not independently associated with severe preeclampsia among affected patients, fetal growth restriction, or composite maternal morbidity. VIF values ranged from 1.00 to 1.07. Secondary models for fetal growth restriction and composite maternal morbidity had borderline events-per-variable values and were interpreted as exploratory. Conclusions: First-trimester Hb/RDW was associated with later documented preeclampsia in this retrospective tertiary-care cohort, but its single-marker performance was modest and specificity was limited. The ratio should be interpreted as an inexpensive research marker of hematologic phenotype rather than a stand-alone screening, diagnostic, or management tool. Prospective multicenter validation with standardized first-trimester sampling and adjustment for hematinic and nutritional variables is required before clinical implementation.
- Open Access
- 20 July 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (4) , 1058-1065
The role of first-trimester hematological parameters in predicting clinically significant postpartum hemoglobin decline: a retrospective study from a perinatology unit
Aims: To evaluate the role of first-trimester hematological parameters in predicting clinically significant postpartum hemoglobin decline.Methods: This retrospective study included 320 pregnant female who delivered at the Perinatology Unit of Şanlıurfa Training and Research Hospital. Participants were divided into two groups according to postpartum hemoglobin decline;
- 20 July 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (4) , 1058-1065
Open AccessThe role of first-trimester hematological parameters in predicting clinically significant postpartum hemoglobin decline: a retrospective study from a perinatology unit
Aims: To evaluate the role of first-trimester hematological parameters in predicting clinically significant postpartum hemoglobin decline.Methods: This retrospective study included 320 pregnant female who delivered at the Perinatology Unit of Şanlıurfa Training and Research Hospital. Participants were divided into two groups according to postpartum hemoglobin decline;
- Open Access
- 16 July 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (4) , 752-758
Maternal iron deficiency anemia is associated with reduced fetal thymic size in the early second trimester
Aims: To evaluate the association between maternal iron-deficiency anemia (IDA) and fetal thymic size in the early second trimester using standardized ultrasonographic measurements.Methods: This prospective observational study included 78 pregnant women with IDA and 78 healthy controls with singleton pregnancies between 20+0 and 24+6 weeks of gestation. A priori power analysis indicated that at least 126 participants (63 per group) were required to provide 80% power. Standardized fetal thoracic and thymic ultrasonography was performed in all participants. Thoracic and thymus anteroposterior (AP) diameters were measured, and the thymic-thoracic ratio (TTR) was calculated. Thymus volume, surface area, and gestational age-adjusted Z-scores were obtained from orthogonal measurements and reference charts. Intraobserver reliability was assessed using the intraclass correlation coefficient (ICC). Because the main ultrasound variables were not normally distributed, group comparisons were performed using the Mann-Whitney U test, and effect sizes were expressed as r. Adjusted linear regression analyses evaluated maternal IDA as the exposure and fetal thymic measurements as outcomes.Results: A total of 189 women were screened, 33 were excluded, and 156 were included in the final analysis. Intraobserver reliability was excellent (ICC=0.91). Maternal age, gestational age at examination, gravidity, and parity were similar between groups, whereas body-mass index was lower in the IDA group (p=0.006, r=0.219). Thoracic AP diameter did not differ significantly between groups (p=0.241). In contrast, fetuses of mothers with IDA had smaller thymus AP diameter (8.0 vs. 8.7 mm, p
- 16 July 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (4) , 752-758
Open AccessMaternal iron deficiency anemia is associated with reduced fetal thymic size in the early second trimester
Aims: To evaluate the association between maternal iron-deficiency anemia (IDA) and fetal thymic size in the early second trimester using standardized ultrasonographic measurements.Methods: This prospective observational study included 78 pregnant women with IDA and 78 healthy controls with singleton pregnancies between 20+0 and 24+6 weeks of gestation. A priori power analysis indicated that at least 126 participants (63 per group) were required to provide 80% power. Standardized fetal thoracic and thymic ultrasonography was performed in all participants. Thoracic and thymus anteroposterior (AP) diameters were measured, and the thymic-thoracic ratio (TTR) was calculated. Thymus volume, surface area, and gestational age-adjusted Z-scores were obtained from orthogonal measurements and reference charts. Intraobserver reliability was assessed using the intraclass correlation coefficient (ICC). Because the main ultrasound variables were not normally distributed, group comparisons were performed using the Mann-Whitney U test, and effect sizes were expressed as r. Adjusted linear regression analyses evaluated maternal IDA as the exposure and fetal thymic measurements as outcomes.Results: A total of 189 women were screened, 33 were excluded, and 156 were included in the final analysis. Intraobserver reliability was excellent (ICC=0.91). Maternal age, gestational age at examination, gravidity, and parity were similar between groups, whereas body-mass index was lower in the IDA group (p=0.006, r=0.219). Thoracic AP diameter did not differ significantly between groups (p=0.241). In contrast, fetuses of mothers with IDA had smaller thymus AP diameter (8.0 vs. 8.7 mm, p
- Open Access
- 7 July 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (7)
Fetal Cardiac Function Shifts Following Tocolytic Therapy With Nifedipine or Magnesium Sulfate: A Comparative Doppler-Based Prospective Assessment
Background: To compare short-term changes in fetal cardiac function following tocolytic therapy with nifedipine or magnesium sulfate (MgSO4) in pregnancies complicated by threatened preterm labor. Methods: This prospective observational study included 316 singleton pregnancies between 32–34 weeks of gestation presenting with threatened preterm labor at a tertiary perinatology clinic. Women received either oral nifedipine (n = 280) as first-line tocolysis or intravenous MgSO4 (n = 36) when nifedipine and indomethacin was contraindicated. Fetal echocardiography was performed within 2 h before initiation and 2–4 h after cessation of tocolysis. Mitral and tricuspid E and A velocities, E/A ratios, left and right myocardial performance indices (MPI), and fetal heart rate (FHR) were recorded. Pre-and post-treatment changes, as well as between-group differences, were analyzed. Receiver operating characteristic (ROC) curves were constructed to assess the discriminative performance of cardiac indices. Results: A total of 316 pregnant women were included in the analysis, with 280 receiving nifedipine and 36 receiving MgSO4. Baseline demographic and clinical characteristics were comparable between groups, except for a slightly higher gestational age and longer duration of tocolysis in the MgSO4 group. In the nifedipine group, post-treatment mitral and tricuspid E/A ratios increased significantly, accompanied by a small but statistically significant decrease in left ventricular MPI and a significant decrease in FHR. In the MgSO4 group, E/A ratios increased significantly after treatment, whereas individual E and A wave velocities and MPI showed no significant changes. In both groups, FHR decreased significantly after treatment. ROC analyses demonstrated limited to moderate discriminative performance of individual cardiac parameters in distinguishing pre- and post-tocolysis states. Conclusions: Both nifedipine and MgSO4 were associated with short-term alterations in fetal diastolic filling parameters following tocolysis. Nifedipine additionally showed a small but statistically significant decrease in left ventricular myocardial performance index (MPI). All observed changes remained within physiologically acceptable ranges for late gestation, supporting the fetal cardiac safety of both agents when used for tocolysis. Clinical Trial Registration: The study has been registered on https://clinicaltrials.gov/ (registration number: NCT06904534; registration link: https://clinicaltrials.gov/study/NCT06904534?cond=NCT06904534&viewType=Card&rank=1).
- 7 July 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (7)
Open AccessFetal Cardiac Function Shifts Following Tocolytic Therapy With Nifedipine or Magnesium Sulfate: A Comparative Doppler-Based Prospective Assessment
Background: To compare short-term changes in fetal cardiac function following tocolytic therapy with nifedipine or magnesium sulfate (MgSO4) in pregnancies complicated by threatened preterm labor. Methods: This prospective observational study included 316 singleton pregnancies between 32–34 weeks of gestation presenting with threatened preterm labor at a tertiary perinatology clinic. Women received either oral nifedipine (n = 280) as first-line tocolysis or intravenous MgSO4 (n = 36) when nifedipine and indomethacin was contraindicated. Fetal echocardiography was performed within 2 h before initiation and 2–4 h after cessation of tocolysis. Mitral and tricuspid E and A velocities, E/A ratios, left and right myocardial performance indices (MPI), and fetal heart rate (FHR) were recorded. Pre-and post-treatment changes, as well as between-group differences, were analyzed. Receiver operating characteristic (ROC) curves were constructed to assess the discriminative performance of cardiac indices. Results: A total of 316 pregnant women were included in the analysis, with 280 receiving nifedipine and 36 receiving MgSO4. Baseline demographic and clinical characteristics were comparable between groups, except for a slightly higher gestational age and longer duration of tocolysis in the MgSO4 group. In the nifedipine group, post-treatment mitral and tricuspid E/A ratios increased significantly, accompanied by a small but statistically significant decrease in left ventricular MPI and a significant decrease in FHR. In the MgSO4 group, E/A ratios increased significantly after treatment, whereas individual E and A wave velocities and MPI showed no significant changes. In both groups, FHR decreased significantly after treatment. ROC analyses demonstrated limited to moderate discriminative performance of individual cardiac parameters in distinguishing pre- and post-tocolysis states. Conclusions: Both nifedipine and MgSO4 were associated with short-term alterations in fetal diastolic filling parameters following tocolysis. Nifedipine additionally showed a small but statistically significant decrease in left ventricular myocardial performance index (MPI). All observed changes remained within physiologically acceptable ranges for late gestation, supporting the fetal cardiac safety of both agents when used for tocolysis. Clinical Trial Registration: The study has been registered on https://clinicaltrials.gov/ (registration number: NCT06904534; registration link: https://clinicaltrials.gov/study/NCT06904534?cond=NCT06904534&viewType=Card&rank=1).
- 22 May 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (3) , 460-465
Predictive value of the first-trimester β-hCG/PAPP-A ratio for gestational diabetes mellitus: a retrospective cohort study
Aims: To evaluate the predictive value of the first-trimester β-hCG/PAPP-A ratio for subsequent gestational diabetes mellitus (GDM) in pregnant women undergoing routine antenatal care.Methods: This retrospective cohort study was conducted in the Perinatology Department of Şanlıurfa Training and Research Hospital and included singleton pregnancies followed between January 2024 and January 2026. Maternal demographic characteristics, obstetric history, first-trimester free beta-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) values, calculated β-hCG/PAPP-A ratio, and GDM status were retrieved from electronic medical records. Women with pregestational diabetes or incomplete data were excluded. Biochemical markers were compared between women with and without GDM. Correlation analysis, logistic regression, and receiver operating characteristic (ROC) analysis were performed.Results: A total of 240 pregnant women were included, of whom 42 (17.5%) developed GDM. Women who developed GDM were older and had higher gravida and parity values. First-trimester PAPP-A levels were significantly lower, whereas the β-hCG/PAPP-A ratio was significantly higher in the GDM group. In multivariate logistic regression analysis, maternal age, lower PAPP-A, and higher β-hCG/PAPP-A ratio remained independently associated with GDM. In ROC analysis, PAPP-A showed the best discriminative performance, while the β-hCG/PAPP-A ratio demonstrated moderate predictive ability.Conclusion: Lower first-trimester PAPP-A levels and a higher β-hCG/PAPP-A ratio were associated with subsequent GDM. Although these markers are insufficient for stand-alone screening, they may contribute to early risk stratification when interpreted within a broader clinical framework.
- 22 May 2026
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 8 (3) , 460-465
Predictive value of the first-trimester β-hCG/PAPP-A ratio for gestational diabetes mellitus: a retrospective cohort study
Aims: To evaluate the predictive value of the first-trimester β-hCG/PAPP-A ratio for subsequent gestational diabetes mellitus (GDM) in pregnant women undergoing routine antenatal care.Methods: This retrospective cohort study was conducted in the Perinatology Department of Şanlıurfa Training and Research Hospital and included singleton pregnancies followed between January 2024 and January 2026. Maternal demographic characteristics, obstetric history, first-trimester free beta-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) values, calculated β-hCG/PAPP-A ratio, and GDM status were retrieved from electronic medical records. Women with pregestational diabetes or incomplete data were excluded. Biochemical markers were compared between women with and without GDM. Correlation analysis, logistic regression, and receiver operating characteristic (ROC) analysis were performed.Results: A total of 240 pregnant women were included, of whom 42 (17.5%) developed GDM. Women who developed GDM were older and had higher gravida and parity values. First-trimester PAPP-A levels were significantly lower, whereas the β-hCG/PAPP-A ratio was significantly higher in the GDM group. In multivariate logistic regression analysis, maternal age, lower PAPP-A, and higher β-hCG/PAPP-A ratio remained independently associated with GDM. In ROC analysis, PAPP-A showed the best discriminative performance, while the β-hCG/PAPP-A ratio demonstrated moderate predictive ability.Conclusion: Lower first-trimester PAPP-A levels and a higher β-hCG/PAPP-A ratio were associated with subsequent GDM. Although these markers are insufficient for stand-alone screening, they may contribute to early risk stratification when interpreted within a broader clinical framework.
- 17 February 2026
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- p. 1-10
Neurosonographic Insights into Maternal Vitamin D Deficiency: Early Markers of Fetal Cortical Development
Objective: The aim of this study was to investigate the association between maternal vitamin D status and fetal cortical maturation using detailed neurosonographic assessment at 28–30 weeks of gestation. Methods: This prospective observational study included 422 singleton pregnancies evaluated between 28 and 30 gestational weeks. Maternal serum 25-hydroxyvitamin D [25(OH)D] was measured by chemiluminescence immunoassay and categorized as deficient (30 ng/mL). Fetal neurosonography was performed with a GE Voluson E8 system to quantify sulcal depths (insula, Sylvian, parieto-occipital, calcarine, and cingulate fissures), corpus callosum thickness, cavum septum pellucidum length, operculization, and cortical maturation grades. Interobserver reliability, correlation, regression, and receiver operating characteristic (ROC) analyses were conducted. Results: Of 422 women, 280 (66.4%) were vitamin D deficient, 110 (26.1%) insufficient, and 32 (7.6%) sufficient. Deficient participants showed significantly lower mean insula, parieto-occipital, and calcarine fissure depths and thinner corpus callosum (p < 0.05). Operculization and cortical maturation grades were also reduced (p = 0.02 and p = 0.01, respectively). Maternal 25(OH)D levels positively correlated with calcarine fissure depth (r = 0.42, p < 0.001) and cortical maturation grade (r = 0.45, p < 0.001). After adjustment for gestational age, vitamin D deficiency independently predicted low cortical maturation (≤ grade 3) (adjusted OR 2.56, 95% CI: 1.34–4.89, p = 0.004). ROC analysis demonstrated good discriminatory ability (AUC = 0.74, p < 0.001), with an optimal vitamin D threshold of ≈ 21 ng/mL yielding 78% sensitivity and 65% specificity. Conclusion: Maternal vitamin D deficiency during the late second to early third trimester is associated with delayed fetal cortical sulcation and reduced operculization grades. Quantitative neurosonography can noninvasively identify early neurodevelopmental vulnerability related to suboptimal maternal vitamin D status, supporting the role of adequate vitamin D as a modifiable determinant of fetal brain development. Given the high prevalence of hypovitaminosis D observed in this cohort, assessment of maternal 25(OH)D levels may be justified in high-risk or high-prevalence populations. Based on commonly applied clinical thresholds, supplementation of approximately 600 IU/day for vitamin D-sufficient women, 1,000 IU/day for those with insufficiency, and 1,500–2,000 IU/day for deficient women may be considered.
- 17 February 2026
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- p. 1-10
Neurosonographic Insights into Maternal Vitamin D Deficiency: Early Markers of Fetal Cortical Development
Objective: The aim of this study was to investigate the association between maternal vitamin D status and fetal cortical maturation using detailed neurosonographic assessment at 28–30 weeks of gestation. Methods: This prospective observational study included 422 singleton pregnancies evaluated between 28 and 30 gestational weeks. Maternal serum 25-hydroxyvitamin D [25(OH)D] was measured by chemiluminescence immunoassay and categorized as deficient (30 ng/mL). Fetal neurosonography was performed with a GE Voluson E8 system to quantify sulcal depths (insula, Sylvian, parieto-occipital, calcarine, and cingulate fissures), corpus callosum thickness, cavum septum pellucidum length, operculization, and cortical maturation grades. Interobserver reliability, correlation, regression, and receiver operating characteristic (ROC) analyses were conducted. Results: Of 422 women, 280 (66.4%) were vitamin D deficient, 110 (26.1%) insufficient, and 32 (7.6%) sufficient. Deficient participants showed significantly lower mean insula, parieto-occipital, and calcarine fissure depths and thinner corpus callosum (p < 0.05). Operculization and cortical maturation grades were also reduced (p = 0.02 and p = 0.01, respectively). Maternal 25(OH)D levels positively correlated with calcarine fissure depth (r = 0.42, p < 0.001) and cortical maturation grade (r = 0.45, p < 0.001). After adjustment for gestational age, vitamin D deficiency independently predicted low cortical maturation (≤ grade 3) (adjusted OR 2.56, 95% CI: 1.34–4.89, p = 0.004). ROC analysis demonstrated good discriminatory ability (AUC = 0.74, p < 0.001), with an optimal vitamin D threshold of ≈ 21 ng/mL yielding 78% sensitivity and 65% specificity. Conclusion: Maternal vitamin D deficiency during the late second to early third trimester is associated with delayed fetal cortical sulcation and reduced operculization grades. Quantitative neurosonography can noninvasively identify early neurodevelopmental vulnerability related to suboptimal maternal vitamin D status, supporting the role of adequate vitamin D as a modifiable determinant of fetal brain development. Given the high prevalence of hypovitaminosis D observed in this cohort, assessment of maternal 25(OH)D levels may be justified in high-risk or high-prevalence populations. Based on commonly applied clinical thresholds, supplementation of approximately 600 IU/day for vitamin D-sufficient women, 1,000 IU/day for those with insufficiency, and 1,500–2,000 IU/day for deficient women may be considered.